Constitutional complex chromosomal rearrangements (CCRs) are rare events that typically involve 2 or more chromosomes with at least 3 breakpoints and can result in normal or abnormal phenotypes depending on whether they disturb the euchromatic neighborhood. Here, we report an unusual balanced CCR involving chromosomes 1, 9, and 10 that causes an unbalanced karyotype in a severely affected toddler. The CCR was initially reported as a maternal 2-way translocation but was reclassified as a 3-way translocation after a microarray analysis of the propositus revealed the involvement of another chromosome not identified by G-banding in his phenotypically normal mother. FISH assays on maternal metaphase cells confirmed that the 1qter region of der(1) was translocated to der(10), whereas the 10qter segment was translocated to der(9), which in turn donated a segment to der(1). Subsequently, this CCR was also identified in her phenotypically normal father (the patient's grandfather). Thus, the patient inherited the previously unreported pathogenic combination of der(1) with a loss of 1q43→qter (including AKT3, ZBTB18, HNRNPU, and SMYD3) and der(9) with a gain of 10q25.2→qter (including FGFR2), leading to a compound phenotype with key features of the 1q43→qter deletion and distal 10q trisomy syndromes. Our observations suggest that the loss of SMYD3 accounts for cardiac defects in a subset of patients. Moreover, due to recurrent miscarriages in this family, our findings allowed improved genetic counseling.

Keywords:
Array CGH, Chromosomal complex rearrangement, Compound phenotype, Distal 10q trisomy syndrome, Three-way translocation, 1q43→qter deletion syndrome
1.
Al-Sarraj Y, Al-Khair HA, Taha RZ, Khattab N, El Sayed ZH, et al: Distal trisomy 10q syndrome, report of a patient with duplicated q24.31-qter, autism spectrum disorder and unusual features. Clin Case Rep 2:201-205 (2014).
2.
Bartholdi D, Toelle SP, Steiner B, Boltshauser E, Schinzel A, Riegel M: Blepharophimosis and mental retardation (BMR) phenotypes caused by chromosomal rearrangements: description in a boy with partial trisomy 10q and monosomy 4q and review of the literature. Eur J Med Genet 51:113-123 (2008).
3.
Berend SA, Bodamer OA, Shapira SK, Shaffer LG, Bacino CA: Familial complex chromosomal rearrangement resulting in a recombinant chromosome. Am J Med Genet 109:311-317 (2002).
4.
Carter MT, Dyack S, Richer J: Distal trisomy 10q syndrome: phenotypic features in a child with inverted duplicated 10q25.1-q26.3. Clin Dysmorphol 19:140-145 (2010).
5.
Cretu Stancu M, van Roosmalen MJ, Renkens I, Nieboer MM, Middelkamp S, et al: Mapping and phasing of structural variation in patient genomes using nanopore sequencing. Nat Commun 8:1326 (2017).
6.
de Munnik SA, García-Miñaúr S, Hoischen A, van Bon BW, Boycott KM, et al: A de novo non-sense mutation in ZBTB18 in a patient with features of the 1q43q44 microdeletion syndrome. Eur J Hum Genet 22:844-846 (2014).
7.
Fukami M, Shima H, Suzuki E, Ogata T, Matsubara K, Kamimaki T: Catastrophic cellular events leading to complex chromosomal rearrangements in the germline. Clin Genet 91:653-660 (2017).
8.
Gu H, Jiang JH, Li JY, Zhang YN, Dong XS, et al: A familial Cri-du-Chat/5p deletion syndrome resulted from rare maternal complex chromosomal rearrangements (CCRs) and/or possible chromosome 5p chromothripsis. PLoS One 8:e76985 (2013).
9.
Hemming IA, Forrest AR, Shipman P, Woodward KJ, Walsh P, et al: Reinforcing the association between distal 1q CNVs and structural brain disorder: a case of a complex 1q43-q44 CNV and a review of the literature. Am J Med Genet B Neuropsychiatr Genet 171B:458-467 (2016).
10.
Kloosterman WP, Guryev V, van Roosmalen M, Duran KJ, de Bruijn E, et al: Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. Hum Mol Genet 20:1916-1924 (2011).
11.
ISCN 2016: An International System for Human Cytogenomic Nomenclature; McGowan-Jordan J, Simons A, Schmid M (eds). Cytogenet Genome Res 149:1-140 (2016).
12.
Lall M, Thakur S, Puri R, Verma I, Mukerji M, Jha P: A 54 Mb 11qter duplication and 0.9 Mb 1q44 deletion in a child with laryngomalacia and agenesis of corpus callosum. Mol Cytogenet 4:19 (2011).
13.
Liehr T, Kosayakova N, Schröder J, Ziegler M, Kreskowski K, et al: Evidence for correlation of fragile sites and chromosomal breakpoints in carriers of constitutional balanced chromosomal rearrangements. Balkan J Med Genet 14:13-16 (2011).
14.
Madan K, Nieuwint AW, van Bever Y: Recombination in a balanced complex translocation of a mother leading to a balanced reciprocal translocation in the child. Review of 60 cases of balanced complex translocations. Hum Genet 99:806-815 (1997).
15.
Mansukhani A, Bellosta P, Sahni M, Basilico C: Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J Cell Biol 149:1297-1308 (2000).
16.
Neira VA, Córdova-Fletes C, Grondin Y, Ramirez-Velazco A, Figuera LE, et al: Complex 9p rearrangement in an XY patient with ambiguous genitalia and features of both 9p duplication and deletion. Am J Med Genet A 158A:1498-1502 (2012).
17.
Nguyen MH, Morel F, Pennamen P, Parent P, Douet-Guilbert N, et al: Balanced complex chromosome rearrangement in male infertility: case report and literature review. Andrologia 47:178-185 (2015).
18.
Pellestor F, Anahory T, Lefort G, Puechberty J, Liehr T, et al: Complex chromosomal rearrangements: origin and meiotic behavior. Hum Reprod Update 17:476-494 (2011).
19.
Rivera H, Domínguez MG: A familial rearrangement(3;5;9) with paternal and maternal transmission leading to a duplication 3p/deletion 5p infant. Clinics (Sao Paulo) 67:669-671 (2012).
20.
Scriven PN, Bint SM, Davies AF, Ogilvie CM: Meiotic outcomes of three-way translocations ascertained in cleavage-stage embryos: refinement of reproductive risks and implications for PGD. Eur J Hum Genet 22:748-753 (2014).
21.
Tracy C, Warren JS, Szulik M, Wang L, Garcia J, et al: The Smyd family of methyltransferases: role in cardiac and skeletal muscle physiology and pathology. Curr Opin Physiol 1:140-152 (2018).
22.
Tulay P, Gultomruk M, Findikli N, Bahceci M: Poor embryo development and preimplantation genetic diagnosis outcomes of translocations involving chromosome 10: do we blame genetics? Zygote 23:778-784 (2015).
© 2019 S. Karger AG, Basel
2019
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.